B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary Cirrhosis

Conditions:   Fatigue;   Primary Biliary CirrhosisInterventions:   Biological: Rituximab;   Other: PlaceboSponsors:   Newcastle-upon-Tyne Hospitals NHS Trust;   National Institute for Health Research, United Kingdom;   Department of Health, United Kingdom;   Newcastle UniversityRecruiting - verified March 2015

Source: ClinicalTrials.gov - February 24, 2015 Category: Research Source Type: clinical trials